Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$4.18B
+8.3% from 2023
Prescriptions
240K
$17,426.30 per claim
Patients
39K
11,470 prescribers
Total spending, 2024
$4.18B
$107,530.91 per patient
Medicare prescription drug plans paid $4.18B for Revlimid in 2024, for 239,782 prescriptions and refills to 38,856 patients (up 8.3% from 2023). The average cost per claim was $17,426.30.
Florida had the highest Medicare cost for Revlimid in 2024: $404.9M for 23,726 claims, followed by California ($293.3M).
Parameswaren Venugopal, hematology-oncology in Chicago, IL, had the highest Medicare cost for Revlimid in 2024: 544 claims costing $11.2M.
Revlimid is made by Bristol-Myers Squibb Company (BMY), listed in the Medicare spending data as Celgene/BMS.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Parameswaren Venugopal Chicago, IL | Hematology-Oncology | 544 | 67 | $11.2M |
| Zachary Hruska Charlottesville, VA | Nurse Practitioner | 587 | 62 | $11.2M |
| John M Burke |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 12,171 | 329,258 | 45,546 | $5.93B |
| 2023 | 11,315 | 216,143 | 36,944 | $3.86B |
| 2024 | 11,470 | 239,782 | 38,856 | $4.18B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 418 |
| 52 |
| $9.0M |
| Erica L Campagnaro Ann Arbor, MI | Hematology | 428 | 106 | $7.7M |
| Areyl D Goff Milwaukee, WI | Nurse Practitioner | 395 | 88 | $7.7M |
| Catharine E Skoog Milwaukee, WI | Physician Assistant | 413 | 84 | $7.4M |
| Keith E Stockerl-Goldstein Saint Louis, MO | Medical Oncology | 352 | 46 | $7.1M |
| Kerry L Bondy Ann Arbor, MI | Physician Assistant | 384 | 100 | $6.9M |
| Jayesh Mehta Chicago, IL | Hematology | 381 | 60 | $6.9M |
| Sarah A Holstein Omaha, NE | Hematology-Oncology | 398 | 39 | $6.7M |
| Kim A Zawodni Ann Arbor, MI | Nurse Practitioner | 347 | 90 | $6.4M |
| Erica Stevens North Haven, CT | Nurse Practitioner | 350 | 72 | $6.3M |
| Tara B Anderson New Haven, CT | Physician Assistant | 356 | 71 | $6.2M |
| Claudia E Paba Prada Pembroke Pines, FL | Hematology-Oncology | 350 | 40 | $6.1M |
| Ami P Ndiaye Charlotte, NC | Nurse Practitioner | 323 | 107 | $5.9M |
| Patrick A Hagen Maywood, IL | Hematology-Oncology | 317 | 42 | $5.9M |
| Matthew J Pianko Ann Arbor, MI | Hematology | 318 | 82 | $5.8M |
| Suzan Rosen Miami, FL | Nurse Practitioner | 306 | 66 | $5.6M |
| John P Winters III Westbrook, ME | Hematology-Oncology | 307 | 33 | $5.4M |
| Carol Huff Baltimore, MD | Medical Oncology | 299 | 47 | $5.2M |
| Benjamin Derman Chicago, IL | Hematopoietic Cell Transplantation and Cellular Therapy | 280 | 37 | $5.2M |
| Emerentia A Agyemang Boston, MA | Nurse Practitioner | 299 | 61 | $5.2M |
| Yenny Garcia Miami, FL | Nurse Practitioner | 317 | 57 | $5.1M |
| Mark A Schroeder Saint Louis, MO | Hematology-Oncology | 248 | 30 | $4.8M |
| Seth M Maliske Iowa City, IA | Hematopoietic Cell Transplantation and Cellular Therapy | 248 | 34 | $4.7M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Celgene/BMS BMY | 239,843 | $4.18B |